Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Arizona Governor Signs Workers' Compensation Opioid Legislation
By Brian Allen, VP of Government Affairs
Mitchell
News Release
Kentucky Legislature Passes Workers' Comp Reform Legislation
By Brian Allen, VP of Government Affairs
Workers' Comp
News Release
Risk & Insurance: The Case Manager's Many Hats
Nurse case managers act as a resource of knowledge, assistance and support for injured workers and everyone involved in their care.
Mitchell
News Release
Florida Governor Signs Opioid Legislation
On March 19, 2018, Florida's Governor, Rick Scott, signed HB21. This legislation was proposed to combat the opioid epidemic in Florida.
Workers' Comp
Article
StateWatch: Bill Review March 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
StateWatch: Early Spring 2018
Keep current with new legislation and its potential effect on your organization.